Advanced search
Publication Cover
Journal of Medical Economics Volume 24, 2021 - Issue 1
Submit an article Journal homepage
2,761
Views
7
CrossRef citations to date
0
Altmetric
Pharmacology

Estimation of the value of convenience in taking influenza antivirals in Japanese adult patients between baloxavir marboxil and neuraminidase inhibitors using a conjoint analysis

Naoki Hosogayaa Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan;b Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan
,
Takahiro Takazonoa Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan;c Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, JapanORCID Iconhttps://orcid.org/0000-0002-0696-5386
ORCID Icon,
Akira Yokomasud Medical Affairs, Shionogi & Co., Ltd., Osaka, Japan
,
Shinzo Hiroid Medical Affairs, Shionogi & Co., Ltd., Osaka, Japan
,
Hidetoshi Ikeokad Medical Affairs, Shionogi & Co., Ltd., Osaka, Japan
,
Kosuke Iwasakie Milliman Inc., Tokyo, Japan
,
Tomomi Takeshimae Milliman Inc., Tokyo, JapanCorrespondence[email protected]
&
Hiroshi Mukaea Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan;f Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, JapanORCID Iconhttps://orcid.org/0000-0002-1429-5706
ORCID Icon show all
Pages 244-254 | Received 27 Nov 2020, Accepted 06 Jan 2021, Published online: 12 Feb 2021

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Kenji Kurazono, Hidetoshi Ikeoka, Shinzo Hiroi, Kosuke Iwasaki, Tomomi Takeshima & Manabu Akazawa. (2022) Estimation of the cost of influenza antiviral medication guidance or support provided by healthcare professionals: a questionnaire survey in Japan. Journal of Medical Economics 25:1, pages 38-50.
Read now

Articles from other publishers (6)

Naoki Hosogaya, Takahiro Takazono, Kenji Kurazono, Shinzo Hiroi, Kosuke Iwasaki, Tomomi Takeshima, Chise Ha & Hiroshi Mukae. (2023) Estimation of Intangible Costs for Factors Associated with Oral Antiviral Drugs for COVID-19 Treatment: A Conjoint Analysis in Japan. Advances in Therapy 40:8, pages 3525-3542.
Crossref
Farzaneh Maleki, Verna Welch, Santiago M. C. Lopez, Alejandro Cane, Jakob Langer, Ashley Enstone, Kristen Markus, Olivia Wright, Nicole Hewitt & Isabelle Whittle. (2023) Understanding the Global Burden of Influenza in Adults Aged 18–64 years: A Systematic Literature Review from 2012 to 2022. Advances in Therapy.
Crossref
Naomi Fujiwara, Takashi Fujiwara & Yuya Ise. (2023) Prescription factors influencing baloxavir prescription during the 2018/2019 and 2019/2020 seasons: a administrative database study in Japan. Journal of Pharmaceutical Health Care and Sciences 9:1.
Crossref
Ataru Igarashi. (2022) Current Status of Formulary in Japan and the Assessment of Various Value Components of Medicines日本におけるフォーミュラリーの現状と医薬品の多面的な価値の評価. YAKUGAKU ZASSHI 142:12, pages 1379-1390.
Crossref
Kenji Kurazono, Hidetoshi Ikeoka, Shinzo Hiroi, Kosuke Iwasaki, Tomomi Takeshima & Daisuke Tamura. (2022) Comparison of Inconvenience Costs Between Influenza Antivirals for Japanese Pediatric Patients: A Conjoint Analysis of Parental Responses. Advances in Therapy 39:4, pages 1724-1742.
Crossref
Basem Al-Omari, Joviana Farhat & Mai Ershaid. (2022) Conjoint Analysis: A Research Method to Study Patients’ Preferences and Personalize Care. Journal of Personalized Medicine 12:2, pages 274.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.